Source: Hematology, Transfusion and Cell Therapy. Unidades: ICB, FMRP, EP
Subjects: FARMACOLOGIA, ESTUDOS DE COORTES, PACIENTES, DOENÇAS DA MEDULA ÓSSEA, NEOPLASIAS ÓSSEAS, MUTAÇÃO GENÉTICA, POLICITEMIA, TROMBOCITOSE
ABNT
SOARES, Moysés Antonio Porto et al. Clinical and molecular profile of a Brazilian cohort of patients with classical BCR-ABL1-negative myeloproliferative neoplasms. Hematology, Transfusion and Cell Therapy, v. 42, n. 3, p. 238-244, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.htct.2019.07.008. Acesso em: 12 set. 2024.APA
Soares, M. A. P., Oliveira, R. D. de, Cortopassi, G. M., Machado Neto, J. A., Palma, L. C., & Pontes, L. L. de F. (2020). Clinical and molecular profile of a Brazilian cohort of patients with classical BCR-ABL1-negative myeloproliferative neoplasms. Hematology, Transfusion and Cell Therapy, 42( 3), 238-244. doi:10.1016/j.htct.2019.07.008NLM
Soares MAP, Oliveira RD de, Cortopassi GM, Machado Neto JA, Palma LC, Pontes LL de F. Clinical and molecular profile of a Brazilian cohort of patients with classical BCR-ABL1-negative myeloproliferative neoplasms [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42( 3): 238-244.[citado 2024 set. 12 ] Available from: https://doi.org/10.1016/j.htct.2019.07.008Vancouver
Soares MAP, Oliveira RD de, Cortopassi GM, Machado Neto JA, Palma LC, Pontes LL de F. Clinical and molecular profile of a Brazilian cohort of patients with classical BCR-ABL1-negative myeloproliferative neoplasms [Internet]. Hematology, Transfusion and Cell Therapy. 2020 ; 42( 3): 238-244.[citado 2024 set. 12 ] Available from: https://doi.org/10.1016/j.htct.2019.07.008